Yaz, Yasmin or generic ocelli (drospirenone and ethinyl estradiol) is a fourth generation combined hormone contraceptive used to prevent pregnancy. It is also used to treat moderate acne and symptoms of premenstrual dysphoric disorder (PMDD). Yaz, Yasmin, or ocelli (Yaz) is classified by the FDA as pregnancy category X drug and has been known to cause birth defects in unborn children. So, should not be used during pregnancy or while breastfeeding. Serious side effects of Yaz that require immediate medical attention include: sudden numbness, weakness, confusion, pain behind the eyes or problems with vision, speech or balance, feeling of heaviness or pain in the chest, pain spreading to the arm or shoulder, nausea or sweating, severe headaches, migraines, pain in the calf, leg cramps, swelling of the feet or legs, shortness of breath, coughing up blood or chest pain, stomach pain, loss of appetite, jaundice, bladder problems, high blood pressure, high cholesterol, depression or emotional changes, or a breast lump. Other less serious side effects include decreased sex drive, weight gain and headaches.
Pay attention to any of the side effects mentioned above is crucial since Yaz has been linked to blood clots, heart attacks and strokes. Bayer Corporation began marketing Yaz in 2006. In 2008, the deceptive marketing campaign prompted the FDA to issue a warning letter that has forced the company to correct its misleading television commercials Bayer. The FDA criticized the misleading ads for women with false information that Yaz is an approved treatment for all types of acne, when it was approved only to treat moderate acne. The FDA also said that the commercials suggest that Yaz is approved to treat symptoms of premenstrual syndrome, when it was only approved for the treatment of PMDD. Finally, and importantly, the FDA criticized the ads for important information relating to diminish side effects, such as Yazs association with the development of serious blood clots.
In January 2009, when the campaign began to take corrective Yaz, Yaz birth control pill was already one of the most control over the market. Unfortunately, for women who believed the misleading and who continue to use Yaz, evidence is mounting that Yaz has serious health risks. Yaz contains a synthetic progestin, drospirenone. According to the FDA, drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood, in patients at high risk. This condition can lead to serious heart and health. Recently, several lawsuits were filed by women who claimed to have suffered various ailments, including deep vein thrombosis, pulmonary embolism and stroke. Yaz is also believed to have caused heart attacks and sudden death in young women.
Pay attention to any of the side effects mentioned above is crucial since Yaz has been linked to blood clots, heart attacks and strokes. Bayer Corporation began marketing Yaz in 2006. In 2008, the deceptive marketing campaign prompted the FDA to issue a warning letter that has forced the company to correct its misleading television commercials Bayer. The FDA criticized the misleading ads for women with false information that Yaz is an approved treatment for all types of acne, when it was approved only to treat moderate acne. The FDA also said that the commercials suggest that Yaz is approved to treat symptoms of premenstrual syndrome, when it was only approved for the treatment of PMDD. Finally, and importantly, the FDA criticized the ads for important information relating to diminish side effects, such as Yazs association with the development of serious blood clots.
In January 2009, when the campaign began to take corrective Yaz, Yaz birth control pill was already one of the most control over the market. Unfortunately, for women who believed the misleading and who continue to use Yaz, evidence is mounting that Yaz has serious health risks. Yaz contains a synthetic progestin, drospirenone. According to the FDA, drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood, in patients at high risk. This condition can lead to serious heart and health. Recently, several lawsuits were filed by women who claimed to have suffered various ailments, including deep vein thrombosis, pulmonary embolism and stroke. Yaz is also believed to have caused heart attacks and sudden death in young women.